Health
Scientists are finally ready to roll out malaria vaccines after 30 years in development Bloomberg reports.
According to the World Health Organization, the malaria vaccinations will be carried out in Africa starting this month.
The vaccine during its trials prevented four in 10 malaria cases among children who received four doses in a large study.
GlaxoSmithKline Plc invested $1 billion in the development of the vaccine, meant to tackle the mosquito-borne disease that kills at least half a million people annually. It comes at a time when malaria is making a come back after declining for many years.
The malaria parasite’s uncanny ability to resist drugs and insecticides due to its complicated genes is making efforts to eliminate the disease more difficult.
Additionally, research into the vaccine is struggling to secure more international funding.
01:19
Ebola cases in DR Congo cross 8,000 as EU, US pledge further financial support
02:00
Ebola: Sharp jump in cases in North Kivu while outbreak slows in Ituri
01:02
DR Congo: Young doctor dies of Ebola as cases surge beyond epicentre
02:30
Noma: The neglected disease devastating children in northern Nigeria
Go to video
Fairer vaccine sharing could save millions in next pandemic, study finds
02:01
Kenya: Health workers increasingly concerned in wake of USAID cuts